What is the Impact Factor of Tissue Engineering and Regenerative Medicine?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Tissue Engineering and Regenerative Medicine is 5.10, ranking in quartile Q2 of Web of Science (SCIE).

Is Tissue Engineering and Regenerative Medicine indexed in Web of Science or Scopus?

Yes, Tissue Engineering and Regenerative Medicine is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.970 (Q1) and an H-index of 50.

Who publishes Tissue Engineering and Regenerative Medicine and what is the Article Processing Charge (APC)?

Tissue Engineering and Regenerative Medicine is published by Springer Singapore. The estimated Article Processing Charge (APC) is approximately $3,212 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Tissue Engineering and Regenerative Medicine?

The official ISO-4 abbreviation of Tissue Engineering and Regenerative Medicine is "TISSUE ENG REGEN MED". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #5,143Hybrid

Tissue Engineering and Regenerative Medicine

Abbreviation (ISO):TISSUE ENG REGEN MED

•

Identifier (ISSN):1738-2696(Print)/2212-5469(Online)

•

Publisher:Springer Singapore

Official Website Submission Portal Compare

Clarivate IF (2026)

5.1↑ +1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Tissue Engineering and Regenerative Medicine

WoS Q2

Annual Impact Factor Metric

Current (2026):5.1

Scopus SJR & RankScopus Q1

0.97

#5,143

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

50 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate4.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

92articles/year

20.32% Gold OA•77.53% Original Research

Aims & Scope

Tissue Engineering and Regenerative Medicine (Tissue Eng Regen Med, TERM), the official journal of the Korean Tissue Engineering and Regenerative Medicine Society, is a publication dedicated to providing research- based solutions to issues related to human diseases. This journal publishes articles that report substantial information and original findings on tissue engineering, medical biomaterials, cells therapy, stem cell biology and regenerative medicine.

Topics Covered (Recognized by AI)

Biology95.6%Medicine92.2%Genetics88.9%Chemistry86.8%Biochemistry74.4%Cell biology65.4%Internal medicine55.8%Pathology51.9%Engineering45.9%Stem cell40.5%In vitro38.5%Biomedical engineering37.9%Materials science36.2%Immunology33.6%Organic chemistry32.4%Physics31.9%Anatomy29.2%Surgery28.7%Endocrinology28.6%Mesenchymal stem cell27.1%Gene27%Cell25.4%Tissue engineering21.4%Composite material20.7%

Primary Research Areas

Cell & Tissue Engineering Engineering Biomedical

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CELL & TISSUE ENGINEERING

Rank10/32

IndexSCIE

JCRSCIE2026

ENGINEERING, BIOMEDICAL

Rank37/130

IndexSCIE

JCISCIE2026

CELL & TISSUE ENGINEERING

Rank13/32

IndexSCIE

JCISCIE2026

ENGINEERING, BIOMEDICAL

Rank43/130

IndexSCIE

Category	Index	Rank	Quartile
CELL & TISSUE ENGINEERING	JCRSCIE	10/32	Q2
ENGINEERING, BIOMEDICAL	JCRSCIE	37/130	Q2
CELL & TISSUE ENGINEERING	JCISCIE	13/32	Q2
ENGINEERING, BIOMEDICAL	JCISCIE	43/130	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.1

Articles / Year57

Total Citations16

2025

IF4.1

Articles / Year111

Total Citations331

2024

IF4.4

Articles / Year70

Total Citations635

2023

IF3.6

Articles / Year104

Total Citations1,470

2022

IF—

Articles / Year92

Total Citations1,631

Year	Impact Factor	Articles / Year	Total Citations
2026	5.1	57	16
2025	4.1	111	331
2024	4.4	70	635
2023	3.6	104	1,470
2022	—	92	1,631
2021	4.169	97	2,555
2020	—	81	1,959
2019	2.272	58	1,772
2018	1.216	68	1,892
2017	—	91	2,382
2016	—	77	1,550
2015	—	62	518

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,143Scopus Q1SCImago Profile

Scopus Coverage:2008-2026

•

Scopus Broad Areas:EngineeringMedicine

Scopus Citation Rank (SJR)Q1

0.97

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.33

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,212 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,353

3-Year Documents274

Citable Documents269

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biomedical EngineeringQ1

Medicine (miscellaneous)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区CELL & TISSUE ENGINEERING

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Tissue Engineering and Regenerative Medicine (abbr: TISSUE ENG REGEN MED, ISSN: 1738-2696) is a peer-reviewed international scholarly journal in the field of CELL & TISSUE ENGINEERING, published by Springer Singapore in South Korea since 2012. The periodical holds a Journal Impact Factor (JIF) of 5.10, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.970 (Q1), an H-index of 50.

The journal enforces rigorous peer evaluation with a publication frequency of 6 issues per year, an annual output of approximately 92 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,212 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.